Taysha Gene Therapies (TSHA) Payables (2020 - 2026)
Taysha Gene Therapies (TSHA) reported Payables of $9.16 million for Q2 2026, up 18.8% from $7.71 million a year earlier and up 100.8% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Taysha Gene Therapies posted Payables of $6.28 million, up 74.7% from FY2024.
- Payables has a five-year compound annual growth rate of 25.8% (FY2020 to FY2025).
- By year, Payables came in at $3.59 million in FY2024 (-43.6%), $6.37 million in FY2023 (-41.8%), $10.95 million in FY2022 (-49.7%) and $21.76 million in FY2021 (+991.4%).
- The Q2 2026 figure ranks as the highest quarterly Payables since Q1 2024.
- Year over year, Payables has now increased in each of the last four quarters, with an average decline of 4.8% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q4 2021 (growth of 991.4%); the low point was Q1 2023 (a decline of 59.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.56 million (Q1 2026), $6.28 million (Q4 2025) and $5.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Taysha Gene Therapies | 1.62 Bn | 1.62 Bn | - | 9.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.16 Mn |
| Mar 31, 2026 | 4.56 Mn |
| Dec 31, 2025 | 6.28 Mn |
| Sep 30, 2025 | 5.44 Mn |
| Jun 30, 2025 | 7.71 Mn |
| Mar 31, 2025 | 4.33 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Jun 30, 2024 | 8.72 Mn |
| Mar 31, 2024 | 10.38 Mn |
| Dec 31, 2023 | 6.37 Mn |
| Sep 30, 2023 | 7.52 Mn |
| Jun 30, 2023 | 10.77 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 10.95 Mn |
| Sep 30, 2022 | 15.25 Mn |
| Jun 30, 2022 | 23.97 Mn |
| Mar 31, 2022 | 22.00 Mn |
| Dec 31, 2021 | 21.76 Mn |
| Sep 30, 2021 | 22.05 Mn |
API Access
Taysha Gene Therapies Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();